A clinician described a case last month: a patient with a partial-thickness burn from a kitchen accident, anxious about pain during dressing changes and the risk of infection. Early in reviewing wound protocols, the instinct might have been to reach for the newest synthetic option on the market. The question that comes first now is different: what do actual outcomes from burn units and plastic surgery practices show about established dressings that have been in routine use for decades?

Composition and How Xeroform Petrolatum Dressing Works

Xeroform petrolatum dressing consists of a fine-mesh absorbent gauze impregnated with a blend of petrolatum, which is a purified form of petroleum jelly, and 3 percent bismuth tribromophenate. The petrolatum component creates an occlusive barrier that helps retain moisture at the wound surface. This moist environment supports the migration of epithelial cells and reduces the formation of scabs that can slow healing. Bismuth tribromophenate adds bacteriostatic properties, meaning it inhibits the growth of certain bacteria rather than acting as a full-spectrum antibiotic that kills organisms outright. The dressing remains non-adherent, so it lifts away without pulling on newly formed tissue during changes.

Application typically begins with cleaning the wound according to standard protocols. The gauze is cut or folded to fit the area and placed directly on the wound bed. A secondary dressing may cover it for protection and absorption of any minimal exudate. Change frequency depends on the amount of drainage and clinical judgment, often every one to three days for many partial-thickness injuries.

Development and Timeline of Use in Medicine

Xeroform petrolatum dressing has served burn and reconstructive surgery settings for decades as a donor-site covering and a protective layer over partial-thickness burns or surgical wounds. Its formulation builds on earlier petrolatum-based products by incorporating the bismuth compound to address bacterial concerns common in open wounds. A 1971 patent addressed stable bismuth tribromophenate ointments for burn treatment, reflecting ongoing refinement of these mixtures, though routine clinical adoption of the impregnated gauze version extends further back in practice records from specialized centers.

The combination proved practical because it combined moisture retention with a mild antimicrobial effect and low cost compared with many modern alternatives. Burn units adopted it widely because it performed reliably across donor sites and superficial burns without requiring frequent interventions that increase patient discomfort.

Photo by Diana Polekhina on Unsplash

Primary Clinical Applications

Clinicians reach for Xeroform petrolatum dressing most often for first- and second-degree burns, skin-graft donor sites, and low-exudate surgical or traumatic wounds. In hand therapy and outpatient settings it protects healing tissue while allowing some movement. It also appears in protocols for mixed-depth burns where the goal is to allow viable tissue in the zone of stasis to declare itself before deciding on grafting.

One 2023 report examined its use as a bolster in place of synthetic skin substitutes and noted comparable results at lower cost in selected cases. A 2025 comparison with silver sulfadiazine suggested potential advantages in healing progression for certain mixed-depth injuries. These examples illustrate how the dressing fits into broader wound-management strategies rather than serving as a universal solution.

Benefits Supported by Available Evidence

The moist environment created by the petrolatum helps reduce pain associated with dressing changes and supports faster re-epithelialization in appropriate wounds. Bacteriostatic action lowers infection risk in lightly draining sites, and the compound can help control odor. Because the material is inexpensive and widely available in various sizes, it supports consistent supply in both hospital and home-care environments.

A 2017 laboratory evaluation of its antimicrobial spectrum confirmed activity against several common wound pathogens, aligning with long-standing clinical observation in burn and plastic surgery. Real-world use continues because the performance matches the needs of many partial-thickness injuries without the complexity or expense of biologic or silver-based products.

Limitations and Safety Considerations

Xeroform petrolatum dressing suits wounds with light to minimal exudate; heavily draining injuries may require a different primary dressing or more frequent changes. It is not indicated for full-thickness burns or wounds needing aggressive debridement. Rare adverse events, including localized irritation or blistering, have appeared in post-market surveillance reports, underscoring the need for patch testing or close monitoring in sensitive patients.

Healthcare providers weigh these factors against patient-specific details such as wound location, depth, and comorbidities. The dressing works best when paired with overall wound-bed preparation and infection-control measures rather than used in isolation.

Photo by Diana Polekhina on Unsplash

Current Role and Practical Next Steps

Decades of accumulated use in specialized centers provide a practical benchmark: Xeroform petrolatum dressing delivers reliable moisture management and mild antimicrobial support at modest cost for many common wound types. When a patient or care team faces a crossroads about dressing selection, the evidence favors matching the product to the wound characteristics rather than defaulting to either the newest technology or the cheapest option.

A small step this month could be reviewing the wound-care supply list or protocol at your facility or practice and confirming whether Xeroform petrolatum dressing remains stocked and appropriately indicated for the cases seen most often.